ONLY AVAILABLE IN PAID PLANS
Ajovy® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents With Episodic Migraine Compared to Placebo in the Space Trial; Results Published in New England Journal of Medicine
In a significant development, parsippany, n. This story has implications for readers interested in understanding the broader context of current events.